Table 2.
Drug name | Commercial product name | Target gene | Occurrence in top modules | GeneMSA gene-level p-value | IMSGC gene-level p-value |
---|---|---|---|---|---|
Fingolimod | Gilenya | HDAC1 | Central in top module of GeneMSA, present in 75/75 top 1 % GeneMSA modules | 0.263 | 0.249 |
Ocrelizumab | Ocrevus | IL2RA | Present in top modules of IMSGC GWAS and top module of dual evaluation, present in 76/76 top 1 % IMSGC modules | 0.212 | 4.37 × 10−9 |
Dimethyl fumaratea | Tecfidera | KEAP1 | Present in 1/76 IMSGC top one present modules | 0.172 | 2.22 × 10−6 |
RELA | Present in 3/75 top 1 % GeneMSA modules and 7/76 IMSGC top 1 % modules | 0.084 | 1.84 × 10−4 |
aDimethyl fumarate has two target genes from module gene list (KEAP1 and RELA)